The Cooper Companies (COO)
(Delayed Data from NSDQ)
$102.00 USD
-1.55 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $102.07 +0.07 (0.07%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.00 USD
-1.55 (-1.50%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $102.07 +0.07 (0.07%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Zacks News
Here's Why You Should Retain Cerner (CERN) Stock for Now
by Zacks Equity Research
Cerner (CERN) is gaining traction from prudent strategic deals and big data based EHR system. However, weak margin remains a woe.
NextGen's New Platform Set to Improve Patient Engagement
by Zacks Equity Research
The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.
Here's Why You Should Buy Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies (COO) lifts adjusted earnings per share view for fiscal 2020.
Here's Why You Should Hold on to CONMED (CNMD) Stock Now
by Zacks Equity Research
CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.
Coronavirus to Weigh on These 4 Medical Stocks' Q1 Show
by Sreyoshi Mukherjee
The coronavirus pandemic likely to disrupt the first-quarter performances of players in the MedTech space.
Coronavirus-Affected MedTech Drags S&P 500 Index Down
by Trina Mukherjee
Amid uncertainty surrounding the coronavirus outbreak, here are a few S&P 500 MedTech stocks that took a hit.
Cooper Companies (COO) Misses on Q1 Earnings, Lifts View
by Zacks Equity Research
Cooper Companies (COO) gains from core CVI segment in fiscal Q1.
Cooper Cos. (COO) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Cooper Cos. (COO) delivered earnings and revenue surprises of -0.74% and -0.26%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Cooper Companies (COO) Q1 Earnings?
by Zacks Equity Research
Cooper Companies (COO) fiscal first-quarter performance is likely to reflect better-than-expected performance at CVI and CSI, and higher revenues.
PCTEL (PCTI) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
PCTEL's (PCTI) fourth-quarter performance is likely to have benefited from robust 5G scanning receiver business.
Ciena (CIEN) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Ciena's (CIEN) fiscal first-quarter performance is likely to have benefited from its global scale and diversification across geographies and customer segments.
Is a Beat in Store for ABM Industries' (ABM) Q1 Earnings?
by Zacks Equity Research
ABM Industries' (ABM) first-quarter fiscal 2020 revenues are likely to have benefited from organic growth.
Analysts Estimate Cooper Cos. (COO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cooper Cos. (COO) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bleak Outlook for Medical Dental Supplies Industry
by Sreyoshi Mukherjee
Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.
Cooper Cos. (COO) Up 3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cooper Cos. (COO) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cooper Cos. (COO) delivered earnings and revenue surprises of 0.92% and 0.91%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?
Domo (DOMO) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Domo's (DOMO) third-quarter fiscal 2020 results are expected to benefit from an expanding clientele and portfolio strength.
Okta (OKTA) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Okta's (OKTA) continued investments are expected to have kept third-quarter fiscal 2020 margin under pressure despite higher adoption of Identity solutions.
Factors to Consider Ahead of Guidewire's (GWRE) Q1 Earnings
by Zacks Equity Research
Guidewire's (GWRE) Q1 results are expected to reflect gains from robust adoption of cloud-based InsurancePlatform suite of solutions. Rising expenditure on product enhancements might have been a drag.
Cooper Companies (COO) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
by Zacks Equity Research
Patterson Companies (PDCO) has likely gained from strength in Animal Health segment in the fiscal second quarter.
Coupa Software (COUP) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Coupa Software's (COUP) Q3 performance is likely to have gained from an expanding customer base, backed by sturdy adoption of Accelerate and virtual cards for POs.
Cooper Cos. (COO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cooper Cos. (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cooper Cos. (COO) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cooper Cos. (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.